참고문헌
- Philip Sapp J, Lewis R. Eversole et al : Cyst of the oral resions in Contemporary oral and maxillofacial pathology. St. Louis, Mosby 1997
- Bataineh AB, al Qudah M : Treatment of mandibular don-togenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol 86 : 42, 1998 https://doi.org/10.1016/S1079-2104(98)90148-2
- Voorsmit RA, Stoelinga PJ, van Haelst UJ : The management of keratocysts. J Maxillofac Surg 9 : 228, 1981 https://doi.org/10.1016/S0301-0503(81)80049-5
- Sung-Hoon Chung, Eui-Wung Lee : A clinical and histopathologic study of benign odontogenic tumors. J Kor Oral Maxillofac Surg 17(2) : 83, 1991
- Sang-Kweon Cha, Il-Kyu Kim. Seong-Seob Oh et al : Clinical study of cyst in the jaw. J Kor Oral Maxillofac Surg 27(2) : 167, 2001
- Tsuda E, Goto M, Michizuki S et al : Isolation of a novel cytokine from human fibroblast that specifically inhibitsos-teoclastogenesis. Biochem Biophys Res Commun 234 : 137, 1997 https://doi.org/10.1006/bbrc.1997.6603
- Lacey DL, Timms E, Tan HL et al : Osteoprotegerin lig-and is a cytokine that regulates osteoclast differentiation and activation. Cell 93 : 165, 1998 https://doi.org/10.1016/S0092-8674(00)81569-X
- Yasuda H, Shima N, Nakagawa N et al : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 : 3597, 1998
- Fuller K, Wong B, Fox S et al : TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188 : 997, 1998 https://doi.org/10.1084/jem.188.5.997
- O'Brien EA, Williams JH, Marshall MJ : Osteoprotegerin ligand regulates osteoclast adherence to the bone surface of mouse calvaria. Biochem Biophys Res Commun 274 : 281, 2000 https://doi.org/10.1006/bbrc.2000.3129
- Simonet WS, Lacey DL, Dunstan CR et al : Osteoprotegerin. a novel secreted protein involved in the regulation of bone densty. Cell 89 : 309, 1997 https://doi.org/10.1016/S0092-8674(00)80209-3
- Wttrant Y, Theoleyre S, Chipoy C et al : RANKL/ RANK/OPG : new therapeutic targets in bone tumors and associated osteolysis. Bioch et Biophys Acta 1704 : 49, 2004
- Guise T.A, Mundy G.R : Cancer and bone. Endocr Rev 19 : 18, 1998 https://doi.org/10.1210/er.19.1.18
- Lacey DL, Timms E, Tan HL et al : Osteoprotegerin lig-and is a cytokine that regulates osteoclast differentiation and activation. Cell 93 : 165, 1998 https://doi.org/10.1016/S0092-8674(00)81569-X
- Yasuda H, Shima N, Nakagawa N et al : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 : 3597, 1998
- Fuller K, Wong B, Fox S et al : TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188 : 997, 1998 https://doi.org/10.1084/jem.188.5.997
- O'Brien EA, Williams JH, Marshall MJ : Osteoprotegerin ligand regulates osteoclast adherence to the bone surface of mouse calvaria. Biochem Biophys Res Commun 274 : 281, 2000 https://doi.org/10.1006/bbrc.2000.3129
- Wong BG, Rho J, Arron J et al : TRANCE is a novel lig-and of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272 : 25190, 1997 https://doi.org/10.1074/jbc.272.40.25190
- Nagai M, Kyakumoto S, Sato N : Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation. Biochem Biophys Res Commun 269 : 532, 2000 https://doi.org/10.1006/bbrc.2000.2314
- Goltzman D : Osteolysis and cancer. J Clin Invest 107 : 1219, 2001 https://doi.org/10.1172/JCI13073
- Chirgwin J.M, Guise TA : Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit. Rev Eukaryot Gene Expr 10 : 59, 2000
- Croucher PI, Shipman CM, Lippitt J et al : Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma Blood 98 : 3534, 2001 https://doi.org/10.1182/blood.V98.13.3534
- Zhang J, Dai J, Qi Y et al : Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 107 : 1235, 2001 https://doi.org/10.1172/JCI11685
- Guise TA, Chirgwin JM : Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop 415 : S32, 2003 https://doi.org/10.1097/01.blo.0000093055.96273.69
- Blum B, Moseley J, Miller L et al : Measurement of bone morphogenetic proteins and other growth factors in dem-ineralized bone matrix. Orthopedics 27 : 1686, 2004
- Rani CSS, MacDougall M : Dental cells express factors that regulate bone resorption. Mol Cell Biol Res Comm 3 : 145, 2000 https://doi.org/10.1006/mcbr.2000.0205
- Wise GE, Lumpkin SJ, Huang H et al : Osteoprotegerin and osteoclst differentiation factor in tooth eruption. J Dent Res 79 : 1937, 2000 https://doi.org/10.1177/00220345000790120301
- Hiroyuki K, Kiyoshi O : Expression of PTHrP, ODF/RAN-KL and OCIF/OPG in ameloblastoma. J Oral Pathol Med 33 : 46, 2004 https://doi.org/10.1111/j.1600-0714.2004.00204.x
- Tay JYY, Bay BH, Yeo JF et al : Identification of RANKL in osteolytic lesions of the facial skeleton. J Dent Res 83(4) : 349, 2004 https://doi.org/10.1177/154405910408300415
- Grimaud E, Soubigou L, Couillaud S et al : RANKL/OPG ratio in increased in severe osteolysis Am J Pathol 163 : 2021, 2003 https://doi.org/10.1016/S0002-9440(10)63560-2
- Good CR, O'Keefe RJ, Puzas JE et al : Immuno-histochemical study of RANKL in human osteolytic bone tumors. J Surg Oncol 79 : 174, 2002 https://doi.org/10.1002/jso.10067
- Kawamoto S, Ejiri S, Hoshi K et al : Immunolocalization of osteoclast differentiation factor in rat periodontium. Arch Oral Biol 47 : 55, 2002 https://doi.org/10.1016/S0003-9969(01)00088-7
- Horowizt MC, Xi Y, Wilson K et al : Control of osteoclas-togenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 12 : 9, 2001 https://doi.org/10.1016/S1359-6101(00)00030-7
- Miyamoto T, Ohneda O, Arai F et al : Bifurcation of osteo-clasts and dendritic cells from common progenitors. Blood 98 : 2544, 2001 https://doi.org/10.1182/blood.V98.8.2544
- Neville BW, Damm DD, Allen CM et al: Oral and Maillofacial Pathology. Philadelphia, W.B Saunders. 1995, p.594
- Scharffetter K, Balz-Herrmann C, Lagrange W et al : Proliferation kinetics-study of the growth of keratocysts. Morpho-functional explanation for recurrences. J Craniomaxillofac Surg 17 : 226, 1989 https://doi.org/10.1016/S1010-5182(89)80074-5
- Li TJ, Browne RM, Prime SS et al : p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 25 : 249, 1996 https://doi.org/10.1111/j.1600-0714.1996.tb01380.x
- Ahlfors E, Larsson, Sjogren S : The odontogenic keratocyst : a benign cystic tumor? J Oral Maxillofac Surg 42 : 10, 1984 https://doi.org/10.1016/0278-2391(84)90390-2
- Anand VK, Arrowod JP, Krolls SO : Malignant potential of the odontogenic keratocyst. Otolaryngol Head Neck Surg 111 : 124, 1994 https://doi.org/10.1177/019459989411100122
- Forssel K : The primordial cyst, a clinical and radiographic study. Proc Finn Dent Soc 76 : 129, 1980
- Hoon Myoung et al : Odontogenic keratocyst : Review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol 91 : 328, 2001 https://doi.org/10.1067/moe.2001.113109